［1］王荣福.PET/CT肿瘤诊断学.北京：北京大学医学出版社，2007

［2］刘庆伟，刘奇.PET/CT肿瘤学.北京：科学出版社，2006

［3］潘中允.PET诊断学.北京：人民卫生出版社，2005

［4］Sasaki M，Kuwabara Y，Yoshida T，et al.Comparison of MET-PET and FDG-PET for differentiation between benign lesions and malignant tumors of the lung.Ann Nucl Med，2001，15：425-431

［5］Seltzer MA，Yap CS，Silverman DH，et al.The impact of PET on the management of lung cancer：the referring physician'perspective.Nucl Med，2003，43：752-756

［6］Ciernik IF，Dizendor FE，Baumert BG，et al.Radiation treatment planning with an integrated positron emission and computed tomography（PET/CT）：a feasibility study.Int J Radiat Oncal Biol Phys，2003，57（3）：853-863

［7］孙蕊，陈秋松，蔡莉，等. ¹⁸ F-FDG PET/CT在小细胞肺癌分期和预后评估中的价值.中国医学影像技术，2011，27（4）：743-746

［8］Lee YJ，Cho A，Cho BC，et al.High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer.Clin Cancer Res，2009，15（7）：2426-2432